Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mymd Pharmaceuticals Inc (MYMD)

Mymd Pharmaceuticals Inc (MYMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mymd Pharmaceuticals Inc 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205 USA

www.mymd.com P: 856-848-8698

Description:

MyMD Pharmaceuticals Inc. is a clinical stage pharmaceutical company involved in developing therapeutic platforms. MyMD Pharmaceuticals Inc., formerly known as Akers Biosciences Inc., is based in Maryland.

Key Statistics

Overview:

Market Capitalization, $K 7,185
Enterprise Value, $K 5,045
Shares Outstanding, K 2,158
Annual Sales, $ 0 K
Annual Net Income, $ -4,000 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,360 K
EBIT, $ -17,120 K
EBITDA, $ -17,020 K
60-Month Beta 2.17
% of Insider Shareholders 2.63%
% of Institutional Shareholders 9.64%
Float, K 2,101
% Float 97.37%
Short Volume Ratio 0.41

Growth:

1-Year Return -93.93%
3-Year Return -97.31%
5-Year Return -99.67%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 99.04%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -3.30 on 11/14/23
Latest Earnings Date 05/20/24
Earnings Per Share ttm -9.00
EPS Growth vs. Prev Qtr 26.67%
EPS Growth vs. Prev Year -22.22%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 02/15/24

MYMD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -103.16%
Return-on-Assets % -56.50%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.45
Book Value/Share 7.28
Interest Coverage -0.57
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar